Developing novel medicines FOR SEVERE IMMUNE SYSTEM DISORDERS

Recent News : JATT Acquisition Corp. and Zura Bio Limited Announce Definitive Business Combination Agreement to Create NYSE Listed Biotechnology Company | June 17, 2022

New Site Coming Soon

COPYRIGHT © 2022 ZURABIO

ALL RIGHTS RESERVED